NCT03920501

Brief Summary

TELESCOPE will be a cluster randomized clinical trial to ascertain whether the use of an intervention including multidisciplinary round with a board certified physician through tele-critical care and periodic meetings to discuss strategies to improve quality indicators can reduce ICU length of stay of patients admitted to intensive care units (ICUs).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
19,360

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 19, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

August 5, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

September 28, 2021

Status Verified

August 1, 2021

Enrollment Period

1.7 years

First QC Date

April 10, 2019

Last Update Submit

September 23, 2021

Conditions

Keywords

Critical careQuality improvementTele-critical careTelemedicine

Outcome Measures

Primary Outcomes (1)

  • Intensive Care Unit Length of Stay

    Time until discharge from the intensive care unit

    From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days

Secondary Outcomes (10)

  • In-Hospital Mortality

    From date of randomization until the date of hospital discharge or death, whichever comes first, assessed up to 90 days

  • Standardized Resource Use

    From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days

  • Standardized Mortality Rate

    From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days

  • Incidence Density of Central Line-Associated Bloodstream Infection (CLABSI)

    From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days

  • Incidence Density of Ventilator-Associated Pneumonia (VAP)

    From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days

  • +5 more secondary outcomes

Other Outcomes (9)

  • Rate of Patients with Head of the Bed Elevated

    From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days

  • Incidence of Early Reintubation

    From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days

  • Incidence of Accidental Extubation

    From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days

  • +6 more other outcomes

Study Arms (2)

Tele-Critical Care

EXPERIMENTAL

Tele-Critical Care + Audit \& Feedback.

Behavioral: Tele-Critical Care

Usual Care

NO INTERVENTION

Usual Care.

Interventions

Daily multidisciplinary rounds with a board certified physician through tele-critical care focusing on: 1) diagnosis; 2) active problems; and 3) therapeutic goals. In addition, the management of health care quality indicators will be conducted by a specially trained (Science of Improvement) board-certified intensive care physician.

Tele-Critical Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Intensive care units from public hospitals and with at least eight beds
  • Intensive care units with physician and nurses available 24 hours a day

You may not qualify if:

  • Intensive care units with structured multidisciplinary round more than three times a week based in a formal instrument
  • Intensive care units already doing audit \& feedback
  • Dedicated coronary care units/cardiac intensive care units or other specialized units
  • Step-down units
  • Adult patients (\> 18 years old)
  • Admitted after the beginning of the study
  • Admission for other reasons than medical (e.g., judicial cause)
  • Previously included in TELESCOPE (for the primary outcome analysis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Israelita Albert Einstein

São Paulo, 05652-900, Brazil

Location

Related Publications (3)

  • Pereira AJ, Noritomi DT, Dos Santos MC, Correa TD, Ferraz LJR, Schettino GPP, Cordioli E, Morbeck RA, Morais LC, Salluh JIF, Azevedo LCP, Biondi RS, Rosa RG, Cavalcanti AB, Berwanger O, Serpa Neto A, Ranzani OT. Effect of Tele-ICU on Clinical Outcomes of Critically Ill Patients: The TELESCOPE Randomized Clinical Trial. JAMA. 2024 Dec 3;332(21):1798-1807. doi: 10.1001/jama.2024.20651.

  • Ranzani O, Pereira AJ, Santos MCD, Correa TD, Ferraz LJR, Cordioli E, Morbeck RA, Berwanger O, Morais LC, Schettino G, Cavalcanti AB, Rosa RG, Biondi RS, Salluh JIF, Azevedo LCP, Serpa Neto A, Noritomi DT. Statistical analysis of a cluster-randomized clinical trial on adult general intensive care units in Brazil: TELE-critical care verSus usual Care On ICU PErformance (TELESCOPE) trial. Rev Bras Ter Intensiva. 2022 Jan-Mar;34(1):87-95. doi: 10.5935/0103-507x.20220003-pt.

  • Noritomi DT, Ranzani OT, Ferraz LJR, Dos Santos MC, Cordioli E, Albaladejo R, Serpa Neto A, Correa TD, Berwanger O, de Morais LC, Schettino G, Cavalcanti AB, Rosa RG, Biondi RS, Salluh JI, Azevedo LCP, Pereira AJ; TELESCOPE Trial Investigators. TELE-critical Care verSus usual Care On ICU PErformance (TELESCOPE): protocol for a cluster-randomised clinical trial on adult general ICUs in Brazil. BMJ Open. 2021 Jun 21;11(6):e042302. doi: 10.1136/bmjopen-2020-042302.

Study Officials

  • Adriano J Pereira, MD PhD

    Hospital Israelita Albert Einstein

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2019

First Posted

April 19, 2019

Study Start

August 5, 2019

Primary Completion

April 7, 2021

Study Completion

December 31, 2021

Last Updated

September 28, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will share

Data sharing open to researchers not members of the study after two years of the publication of the main study

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
After two years of the first publication
Access Criteria
Data will be acessed through an online repository protected with password and for secondary analyses according to pre-specified plans.

Locations